Current Oncology (Sep 2022)

Updates in Pathology for Retroperitoneal Soft Tissue Sarcoma

  • Tanner Mack,
  • Bibianna Purgina

DOI
https://doi.org/10.3390/curroncol29090504
Journal volume & issue
Vol. 29, no. 9
pp. 6400 – 6418

Abstract

Read online

Retroperitoneal tumors are extremely rare. More than 70% of primary retroperitoneal soft tissue tumors are malignant. The most common sarcomas in the retroperitoneum include liposarcomas and leiomyosarcoma, however other sarcomas, along with benign mesenchymal tumors, can occur. Sarcomas are a heterogenous group of tumors with overlapping microscopic features, posing a diagnostic challenge for the pathologist. Correct tumor classification has become important for prognostication and the evolving targeted therapies for sarcoma subtypes. In this review, the pathology of retroperitoneal soft tissue sarcomas is discussed, which is important to the surgical oncologist. In addition, less common sarcomas and benign mesenchymal tumors of the retroperitoneum, which may mimic sarcoma clinically and pathologically, are also discussed.

Keywords